Cargando…

A Pilot Study Comparing the Efficacy of Lactate Dehydrogenase Levels Versus Circulating Cell-Free microRNAs in Monitoring Responses to Checkpoint Inhibitor Immunotherapy in Metastatic Melanoma Patients

SIMPLE SUMMARY: Improvement in melanoma patients with metastatic disease is needed to better assess immunotherapies. Lactate dehydrogenase (LDH) is currently an accepted biomarker for stage IV, but it has limited utility for stage III melanoma patients. Thus, finding biomarkers for metastatic melano...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bustos, Matias A., Gross, Rebecca, Rahimzadeh, Negin, Cole, Hunter, Tran, Linh T., Tran, Kevin D., Takeshima, Ling, Stern, Stacey L., O’Day, Steven, Hoon, Dave S. B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696545/ https://www.ncbi.nlm.nih.gov/pubmed/33202891 http://dx.doi.org/10.3390/cancers12113361

Ejemplares similares

Integrated Assessment of Circulating Cell-Free MicroRNA Signatures in Plasma of Patients with Melanoma Brain Metastasis
por: Bustos, Matias A., et al.
Publicado: (2020)

Genetic Variants in Immune Related Genes as Predictors of Responsiveness to BCG Immunotherapy in Metastatic Melanoma Patients
por: Ramos, Romela Irene, et al.
Publicado: (2020)

EpiMap: Fine-tuning integrative epigenomics maps to understand complex human regulatory genomic circuitry
por: Hoon, Dave S. B., et al.
Publicado: (2021)

Prognostic value of lactate dehydrogenase in patients with uveal melanoma treated with immune checkpoint inhibition
por: Liang, Xiaocui, et al.
Publicado: (2023)

Usefulness of lactate dehydrogenase in differentiating abnormal cervical lymphadenopathy
por: Kamiya, Naoko, et al.
Publicado: (2020)

Interleukin enhancer‐binding factor 2 promotes cell proliferation and DNA damage response in metastatic melanoma
por: Zhang, Xiaoqing, et al.
Publicado: (2021)

Recent Developments of Circulating Tumor Cell Analysis for Monitoring Cutaneous Melanoma Patients
por: Shoji, Yoshiaki, et al.
Publicado: (2022)

Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma
por: Petrova, Vera, et al.
Publicado: (2020)

Prognostic value of neutrophil-lymphocyte ratio and lactate dehydrogenase in melanoma patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis
por: Zhang, Yongchao, et al.
Publicado: (2022)

Immunotherapy for Melanoma: The Significance of Immune Checkpoint Inhibitors for the Treatment of Advanced Melanoma
por: Fujimura, Taku, et al.
Publicado: (2022)

Prognostic Value of Lactate Dehydrogenase, Melanoma Inhibitory Protein, and S-100B Protein in Patients with Malignant Melanoma
por: Fan, Shuwen, et al.
Publicado: (2022)

Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma
por: Ho, Joel, et al.
Publicado: (2022)

Retracted: Prognostic Value of Lactate Dehydrogenase, Melanoma Inhibitory Protein, and S-100B Protein in Patients with Malignant Melanoma
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Expression of Lactate Dehydrogenase in Aspergillus niger for L-Lactic Acid Production
por: Dave, Khyati K., et al.
Publicado: (2015)

Lactate Dehydrogenase-Elevating Virus
por: Coutelier, Jean-Paul, et al.
Publicado: (2007)

Lactate Dehydrogenase: The Beacon of Hope?
por: Pandarathodiyil, Anitha Krishnan, et al.
Publicado: (2022)

Acetylated DNMT1 Downregulation and Related Regulatory Factors Influence Metastatic Melanoma Patients Survival
por: Zhang, Xiaoqing, et al.
Publicado: (2021)

Natural compounds as lactate dehydrogenase inhibitors: potential therapeutics for lactate dehydrogenase inhibitors-related diseases
por: Han, Jung Ho, et al.
Publicado: (2023)

Checkpoint Inhibitors Immunotherapy in Metastatic Melanoma: When to Stop Treatment?
por: De Risi, Ivana, et al.
Publicado: (2022)

Prognostic Value of Lactate Dehydrogenase in Second-Line Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma
por: Li, Yan, et al.
Publicado: (2022)

Indirect Comparison of Combined BRAF and MEK Inhibition in Melanoma Patients with Elevated Baseline Lactate Dehydrogenase
por: GLUTSCH, Valerie, et al.
Publicado: (2020)

The Pseudomonas aeruginosa Complement of Lactate Dehydrogenases Enables Use of d- and l-Lactate and Metabolic Cross-Feeding
por: Lin, Yu-Cheng, et al.
Publicado: (2018)

Peripheral lymphocytes and lactate dehydrogenase correlate with response and survival in head and neck cancers treated with immune checkpoint inhibitors
por: Pan, Cassie, et al.
Publicado: (2023)

The mitochondrial L-lactate dehydrogenase affair
por: Passarella, Salvatore, et al.
Publicado: (2014)

Lactate dehydrogenase, COVID-19 and mortality
por: Bartziokas, Konstantinos, et al.
Publicado: (2021)

Lactate dehydrogenase, COVID-19 and mortality
por: Bartziokas, Konstantinos, et al.
Publicado: (2021)

Upregulation of cell surface GD3 ganglioside phenotype is associated with human melanoma brain metastasis
por: Ramos, Romela Irene, et al.
Publicado: (2020)

H-2-controlled suppression of T cell response to lactate dehydrogenase B. Characterization of the lactate dehydrogenase B suppressor pathway
Publicado: (1982)

Pretreatment Neutrophil-to-Lymphocyte Ratio and Lactate Dehydrogenase Predict the Prognosis of Metastatic Cervical Cancer Treated with Combination Immunotherapy
por: Cheng, Mingxia, et al.
Publicado: (2022)

Unravelling Tumour Microenvironment in Melanoma at Single-Cell Level and Challenges to Checkpoint Immunotherapy
por: Bai, Xinyu, et al.
Publicado: (2022)

Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis
por: Weide, B, et al.
Publicado: (2012)

Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma
por: Diem, S, et al.
Publicado: (2016)

Pilot Study: Assessing the Expression of Serum Lactate Dehydrogenase and Peripheral Leukocyte Ratios in Canine Oral Malignant Melanoma
por: Murray, Ben, et al.
Publicado: (2022)

Isoenzymes of hexokinase, 6-phosphogluconate dehydrogenase, phosphoglucomutase and lactate dehydrogenase in uterine cancer.
por: Marshall, M. J., et al.
Publicado: (1979)

Pyruvate dehydrogenase complex and lactate dehydrogenase are targets for therapy of acute liver failure
por: Ferriero, Rosa, et al.
Publicado: (2018)

Structure and Function of Lactate Dehydrogenase from Hagfish
por: Nishiguchi, Yoshikazu, et al.
Publicado: (2010)

Salivary lactate dehydrogenase and aminotransferases in diabetic patients
por: Malicka, Barbara, et al.
Publicado: (2016)

Identification of human D lactate dehydrogenase deficiency
por: Monroe, Glen R., et al.
Publicado: (2019)

The Structural Basis of Babesia orientalis Lactate Dehydrogenase
por: Yu, Long, et al.
Publicado: (2022)

Mutual regulation of lactate dehydrogenase and redox robustness
por: Lin, Yijun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0qkum9mfft2q2gg7bdbp8af9t6